Trial Profile
A polymer-free paclitaxel-eluting stent versus the first generation paclitaxel-eluting stent Taxus Liberte in patients with a single de novo coronary lesion
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms PAX-A
- 05 Mar 2011 New trial record